These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Further pharmacological characterization of the selective melanocortin 4 receptor antagonist HS014: comparison with SHU9119. Schiöth HB; Muceniece R; Mutulis F; Bouifrouri AA; Mutule I; Wikberg JE Neuropeptides; 1999 Jun; 33(3):191-6. PubMed ID: 10657491 [TBL] [Abstract][Full Text] [Related]
23. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist. Frändberg PA; Doufexis M; Kapas S; Chhajlani V Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737 [TBL] [Abstract][Full Text] [Related]
24. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides. Getting SJ; Schiöth HB; Perretti M J Pharmacol Exp Ther; 2003 Aug; 306(2):631-7. PubMed ID: 12750433 [TBL] [Abstract][Full Text] [Related]
25. Structure-function relationships and conformational properties of alpha-MSH(6-13) analogues with candidacidal activity. Carotenuto A; Saviello MR; Auriemma L; Campiglia P; Catania A; Novellino E; Grieco P Chem Biol Drug Des; 2007 Jan; 69(1):68-74. PubMed ID: 17313459 [TBL] [Abstract][Full Text] [Related]
26. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites. Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392 [TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template. Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845 [TBL] [Abstract][Full Text] [Related]
28. Anxiety-like behavior induced by IL-1beta is modulated by alpha-MSH through central melanocortin-4 receptors. Cragnolini AB; Schiöth HB; Scimonelli TN Peptides; 2006 Jun; 27(6):1451-6. PubMed ID: 16325304 [TBL] [Abstract][Full Text] [Related]
30. Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats. Kokare DM; Dandekar MP; Chopde CT; Subhedar N Brain Res; 2005 May; 1043(1-2):107-14. PubMed ID: 15862523 [TBL] [Abstract][Full Text] [Related]
31. Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists. Haskell-Luevano C; Sawyer TK; Trumpp-Kallmeyer S; Bikker JA; Humblet C; Gantz I; Hruby VJ Drug Des Discov; 1996 Dec; 14(3):197-211. PubMed ID: 9017363 [TBL] [Abstract][Full Text] [Related]
32. Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity. Hess S; Linde Y; Ovadia O; Safrai E; Shalev DE; Swed A; Halbfinger E; Lapidot T; Winkler I; Gabinet Y; Faier A; Yarden D; Xiang Z; Portillo FP; Haskell-Luevano C; Gilon C; Hoffman A J Med Chem; 2008 Feb; 51(4):1026-34. PubMed ID: 18220330 [TBL] [Abstract][Full Text] [Related]
33. [Detection of binding activity and biologic effect of a novel alpha-melanocyte-stimulating hormone analogue]. Ying Y; Lan XP; Tian YP Yao Xue Xue Bao; 2007 Mar; 42(3):269-73. PubMed ID: 17520825 [TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and biological evaluation of new cyclic melanotropin peptide analogues selective for the human melanocortin-4 receptor. Ying J; Gu X; Cai M; Dedek M; Vagner J; Trivedi DB; Hruby VJ J Med Chem; 2006 Nov; 49(23):6888-96. PubMed ID: 17154518 [TBL] [Abstract][Full Text] [Related]
35. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor. Chaki S; Hirota S; Funakoshi T; Suzuki Y; Suetake S; Okubo T; Ishii T; Nakazato A; Okuyama S J Pharmacol Exp Ther; 2003 Feb; 304(2):818-26. PubMed ID: 12538838 [TBL] [Abstract][Full Text] [Related]
36. Alpha-melanocyte stimulating hormone antagonizes antidepressant-like effect of neuropeptide Y in Porsolt's test in rats. Goyal SN; Kokare DM; Chopde CT; Subhedar NK Pharmacol Biochem Behav; 2006 Oct; 85(2):369-77. PubMed ID: 17052748 [TBL] [Abstract][Full Text] [Related]
37. Involvement of alpha-melanocyte stimulating hormone (alpha-MSH) in differential ethanol exposure and withdrawal related depression in rat: neuroanatomical-behavioral correlates. Kokare DM; Singru PS; Dandekar MP; Chopde CT; Subhedar NK Brain Res; 2008 Jun; 1216():53-67. PubMed ID: 18499089 [TBL] [Abstract][Full Text] [Related]
38. Proteochemometric modeling reveals the interaction site for Trp9 modified alpha-MSH peptides in melanocortin receptors. Lapinsh M; Prusis P; Petrovska R; Uhlén S; Mutule I; Veiksina S; Wikberg JE Proteins; 2007 May; 67(3):653-60. PubMed ID: 17357163 [TBL] [Abstract][Full Text] [Related]
39. NDP-α-MSH induces intense neurogenesis and cognitive recovery in Alzheimer transgenic mice through activation of melanocortin MC4 receptors. Giuliani D; Neri L; Canalini F; Calevro A; Ottani A; Vandini E; Sena P; Zaffe D; Guarini S Mol Cell Neurosci; 2015 Jul; 67():13-21. PubMed ID: 26003413 [TBL] [Abstract][Full Text] [Related]
40. Novel 3D pharmacophore of alpha-MSH/gamma-MSH hybrids leads to selective human MC1R and MC3R analogues. Cai M; Mayorov AV; Cabello C; Stankova M; Trivedi D; Hruby VJ J Med Chem; 2005 Mar; 48(6):1839-48. PubMed ID: 15771429 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]